Ligand Pharmaceuticals Incorporated (FRA:LGDN)
161.00
-4.00 (-2.42%)
At close: Dec 4, 2025
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of €3.13 billion as of December 5, 2025. Its market cap has increased by 56.77% in one year.
Market Cap
3.13B
Enterprise Value
2.94B
Revenue
214.13M
Ranking
n/a
PE Ratio
75.54
Stock Price
€161.00
Market Cap Chart
Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 62.10M to 3.13B, an increase of 4,936.61%. That is a compound annual growth rate of 13.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.93B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |